If you're building a portfolio, then having a few blue chips in there could be a good starting point.
Blue chips are typically large companies that have been operating for many years, have stable cash flows, experienced management teams, and positive outlooks. These qualities can make them a good foundation to build a portfolio from.
But which blue chip ASX 200 shares could be buys now? Listed below are two high-quality options to consider in March:
CSL Limited (ASX: CSL)
The first blue chip ASX 200 share that could be a buy is CSL. It is one of the world's leading biotechnology companies, comprising the CSL Behring, CSL Vifor, and Seqirus businesses.
The team at UBS believes that recent weakness has created a buying opportunity for investors. Particularly given the broker's belief that CSL will deliver double-digit earnings growth over the next three to four years.
UBS has a buy rating and $330.00 price target on the company's shares. This implies potential upside of 17% for investors over the next 12 months.
Goodman Group (ASX: GMG)
Another blue chip ASX 200 share that could be a buy for investors this month is Goodman Group. It is a leading integrated commercial and industrial property company.
Goodman has been growing at a solid rate over the last decade thanks to the success of its strategy of developing high-quality industrial properties in strategic locations. The good news is that this strategy remains in place and Goodman has a huge development pipeline that is expected to drive further growth.
It is for this reason that Macquarie currently has an outperform rating and $34.84 price target on its shares. This suggests potential upside of almost 13% for investors from current levels.
